Table 3.

Metabolic Outcomes in Climacteric Women (Cases) and Preclimacteric Women (Controls) at the Ages of 31 and 46

31 Years
46 Years
VariableMeans ± SD (n =)PaPbMeans ± SD (n =)PaPb
TC, mMCases5.0 ± 1.0 (278)0.4260.1035.4 ± 0.9 (364)<0.001<0.001
Controls4.9 ± 0.9 (1580)5.1 ± 0.8 (2275)
LDL-C, mMCases2.8 ± 0.9 (278)0.1990.0963.4 ± 0.9 (364)0.001<0.001
Controls2.8 ± 0.8 (1576)3.2 ± 0.8 (2275)
HDL-C, mMCases1.7 ± 0.4 (278)0.6020.9891.7 ± 0.4 (364)0.0030.022
Controls1.7 ± 0.4 (1580)1.6 ± 0.4 (2275)
Triglycerides, mMCases1.0 ± 0.6 (278)0.8760.7461.2 ± 0.7 (364)0.0280.008
Controls1.0 ± 0.6 (1580)1.0 ± 0.5 (2275)
T, nMCases1.9 ± 0.7 (148)0.0400.0181.4 ± 0.4 (361)<0.0010.001
Controls2.1 ± 0.9 (873)1.4 ± 0.4 (2271)
FAICases3.4 ± 2.2 (148)0.1640.0091.7 ± 0.9 (362)0.3480.215
Controls3.9 ± 3.1 (870)1.8 ± 2.0 (2273)
hs-CRP, mg/LCases2.2 ± 4.6 (269)0.0060.0561.5 ± 1.8 (362)0.0160.078
Controls2.3 ± 4.0 (1542)1.6 ± 3.2 (2268)
ALT, IU/LCases27.0 ± 21.2 (364)<0.0010.023
Controls23.8 ± 18.4 (2275)
AST, IU/LCases23.3 ± 16.7 (362)<0.0010.243
Controls21.0 ± 27.9 (2274)
GGT, IU/LCases31.5 ± 42.6 (363)<0.001<0.001
Controls25.1 ± 29.6 (2274)
31 Years
46 Years
VariableMeans ± SD (n =)PaPbMeans ± SD (n =)PaPb
TC, mMCases5.0 ± 1.0 (278)0.4260.1035.4 ± 0.9 (364)<0.001<0.001
Controls4.9 ± 0.9 (1580)5.1 ± 0.8 (2275)
LDL-C, mMCases2.8 ± 0.9 (278)0.1990.0963.4 ± 0.9 (364)0.001<0.001
Controls2.8 ± 0.8 (1576)3.2 ± 0.8 (2275)
HDL-C, mMCases1.7 ± 0.4 (278)0.6020.9891.7 ± 0.4 (364)0.0030.022
Controls1.7 ± 0.4 (1580)1.6 ± 0.4 (2275)
Triglycerides, mMCases1.0 ± 0.6 (278)0.8760.7461.2 ± 0.7 (364)0.0280.008
Controls1.0 ± 0.6 (1580)1.0 ± 0.5 (2275)
T, nMCases1.9 ± 0.7 (148)0.0400.0181.4 ± 0.4 (361)<0.0010.001
Controls2.1 ± 0.9 (873)1.4 ± 0.4 (2271)
FAICases3.4 ± 2.2 (148)0.1640.0091.7 ± 0.9 (362)0.3480.215
Controls3.9 ± 3.1 (870)1.8 ± 2.0 (2273)
hs-CRP, mg/LCases2.2 ± 4.6 (269)0.0060.0561.5 ± 1.8 (362)0.0160.078
Controls2.3 ± 4.0 (1542)1.6 ± 3.2 (2268)
ALT, IU/LCases27.0 ± 21.2 (364)<0.0010.023
Controls23.8 ± 18.4 (2275)
AST, IU/LCases23.3 ± 16.7 (362)<0.0010.243
Controls21.0 ± 27.9 (2274)
GGT, IU/LCases31.5 ± 42.6 (363)<0.001<0.001
Controls25.1 ± 29.6 (2274)

The analyses were adjusted for age at menarche, parity, smoking, level of education, and physical activity. The study subjects were participants in the NFBC1966. Climacteric status was determined at the age of 46 by menstrual anamnesis and FSH value.

a

P, crude P value.

b

P, adjusted P value.

Table 3.

Metabolic Outcomes in Climacteric Women (Cases) and Preclimacteric Women (Controls) at the Ages of 31 and 46

31 Years
46 Years
VariableMeans ± SD (n =)PaPbMeans ± SD (n =)PaPb
TC, mMCases5.0 ± 1.0 (278)0.4260.1035.4 ± 0.9 (364)<0.001<0.001
Controls4.9 ± 0.9 (1580)5.1 ± 0.8 (2275)
LDL-C, mMCases2.8 ± 0.9 (278)0.1990.0963.4 ± 0.9 (364)0.001<0.001
Controls2.8 ± 0.8 (1576)3.2 ± 0.8 (2275)
HDL-C, mMCases1.7 ± 0.4 (278)0.6020.9891.7 ± 0.4 (364)0.0030.022
Controls1.7 ± 0.4 (1580)1.6 ± 0.4 (2275)
Triglycerides, mMCases1.0 ± 0.6 (278)0.8760.7461.2 ± 0.7 (364)0.0280.008
Controls1.0 ± 0.6 (1580)1.0 ± 0.5 (2275)
T, nMCases1.9 ± 0.7 (148)0.0400.0181.4 ± 0.4 (361)<0.0010.001
Controls2.1 ± 0.9 (873)1.4 ± 0.4 (2271)
FAICases3.4 ± 2.2 (148)0.1640.0091.7 ± 0.9 (362)0.3480.215
Controls3.9 ± 3.1 (870)1.8 ± 2.0 (2273)
hs-CRP, mg/LCases2.2 ± 4.6 (269)0.0060.0561.5 ± 1.8 (362)0.0160.078
Controls2.3 ± 4.0 (1542)1.6 ± 3.2 (2268)
ALT, IU/LCases27.0 ± 21.2 (364)<0.0010.023
Controls23.8 ± 18.4 (2275)
AST, IU/LCases23.3 ± 16.7 (362)<0.0010.243
Controls21.0 ± 27.9 (2274)
GGT, IU/LCases31.5 ± 42.6 (363)<0.001<0.001
Controls25.1 ± 29.6 (2274)
31 Years
46 Years
VariableMeans ± SD (n =)PaPbMeans ± SD (n =)PaPb
TC, mMCases5.0 ± 1.0 (278)0.4260.1035.4 ± 0.9 (364)<0.001<0.001
Controls4.9 ± 0.9 (1580)5.1 ± 0.8 (2275)
LDL-C, mMCases2.8 ± 0.9 (278)0.1990.0963.4 ± 0.9 (364)0.001<0.001
Controls2.8 ± 0.8 (1576)3.2 ± 0.8 (2275)
HDL-C, mMCases1.7 ± 0.4 (278)0.6020.9891.7 ± 0.4 (364)0.0030.022
Controls1.7 ± 0.4 (1580)1.6 ± 0.4 (2275)
Triglycerides, mMCases1.0 ± 0.6 (278)0.8760.7461.2 ± 0.7 (364)0.0280.008
Controls1.0 ± 0.6 (1580)1.0 ± 0.5 (2275)
T, nMCases1.9 ± 0.7 (148)0.0400.0181.4 ± 0.4 (361)<0.0010.001
Controls2.1 ± 0.9 (873)1.4 ± 0.4 (2271)
FAICases3.4 ± 2.2 (148)0.1640.0091.7 ± 0.9 (362)0.3480.215
Controls3.9 ± 3.1 (870)1.8 ± 2.0 (2273)
hs-CRP, mg/LCases2.2 ± 4.6 (269)0.0060.0561.5 ± 1.8 (362)0.0160.078
Controls2.3 ± 4.0 (1542)1.6 ± 3.2 (2268)
ALT, IU/LCases27.0 ± 21.2 (364)<0.0010.023
Controls23.8 ± 18.4 (2275)
AST, IU/LCases23.3 ± 16.7 (362)<0.0010.243
Controls21.0 ± 27.9 (2274)
GGT, IU/LCases31.5 ± 42.6 (363)<0.001<0.001
Controls25.1 ± 29.6 (2274)

The analyses were adjusted for age at menarche, parity, smoking, level of education, and physical activity. The study subjects were participants in the NFBC1966. Climacteric status was determined at the age of 46 by menstrual anamnesis and FSH value.

a

P, crude P value.

b

P, adjusted P value.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close